| Piramal Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 1,324.35 | 1,322.95 | 1,193.32 | 1,185.91 | 994.60 |
| Reserves | 6,128.19 | 5,389.12 | 4,068.47 | 3,937.21 | 3,105.92 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 7,452.54 | 6,712.07 | 5,261.79 | 5,123.12 | 4,100.62 |
| Secured Loans | 1,009.06 | 895.58 | 1,312.68 | 1,153.78 | 90.20 |
| Unsecured Loans | 234.12 | 281.11 | 336.47 | 10.69 | 84.06 |
| Total Debt | 1,243.18 | 1,176.69 | 1,649.15 | 1,164.47 | 174.26 |
| Other Liabilities | 48.56 | 32.23 | 25.56 | 12.91 | 6.59 |
| Total Liabilities | 8,744.28 | 7,920.99 | 6,936.50 | 6,300.50 | 4,281.47 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4,248.53 | 3,766.97 | 3,564.57 | 3,225.28 | 2,260.11 |
| Less: Accumulated Depreciation | 1,354.25 | 1,154.81 | 962.70 | 786.30 | 633.30 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 2,894.28 | 2,612.16 | 2,601.87 | 2,438.98 | 1,626.81 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 327.30 | 533.24 | 416.57 | 405.16 | 121.00 |
| Investments | 3,105.31 | 1,708.16 | 1,746.99 | 1,629.53 | 1,591.52 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,205.35 | 1,153.04 | 818.61 | 535.51 | 420.88 |
| Sundry Debtors | 1,666.69 | 1,331.38 | 909.56 | 989.22 | 839.75 |
| Cash and Bank Balance | 177.84 | 241.73 | 64.16 | 137.23 | 152.35 |
| Loans and Advances | 486.00 | 504.12 | 456.23 | 403.17 | 354.52 |
| Total Current Assets | 3,535.88 | 3,230.27 | 2,248.56 | 2,065.13 | 1,767.50 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 1,391.57 | 1,348.42 | 872.54 | 845.87 | 1,264.21 |
| Provisions | 42.85 | 84.83 | 39.21 | 53.31 | 40.57 |
| Total CL & Provisions | 1,434.42 | 1,433.25 | 911.75 | 899.18 | 1,304.78 |
| Net Current Assets | 2,101.46 | 1,797.02 | 1,336.81 | 1,165.95 | 462.72 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 56.51 | 49.17 | 33.87 | 12.37 | 1.13 |
| Deferred Tax Liability | 269.64 | 245.81 | 228.02 | 183.73 | 171.55 |
| Net Deferred Tax | -213.13 | -196.64 | -194.15 | -171.36 | -170.42 |
| Other Assets | 529.06 | 1,467.05 | 1,028.41 | 832.24 | 649.84 |
| Total Assets | 8,744.28 | 7,920.99 | 6,936.50 | 6,300.50 | 4,281.47 |
| Contingent Liabilities | 97.27 | 59.25 | 57.32 | 42.81 | 28.19 |